Cargando…
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial
Blockade of the renin-angiotensin-aldosterone system exhibits a renoprotective effect; however, blockade of this system may also decrease hemoglobin (Hb) and erythropoietin (EPO) levels. We evaluated the correlation between reduced albuminuria and decreased hemoglobin concentrations after treatment...
Autores principales: | An, Jung Nam, Hwang, Jin Ho, Lee, Jung Pyo, Chin, Ho Jun, Kim, Sejoong, Kim, Dong Ki, Kim, Suhnggwon, Park, Jung Hwan, Shin, Sung Joon, Lee, Sang Ho, Choi, Bum Soon, Lim, Chun Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476682/ https://www.ncbi.nlm.nih.gov/pubmed/26098847 http://dx.doi.org/10.1371/journal.pone.0128632 |
Ejemplares similares
-
Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial
por: Han, Seung Seok, et al.
Publicado: (2015) -
Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients
por: Yu, Mi-Yeon, et al.
Publicado: (2018) -
Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease
por: Ahn, Shin Young, et al.
Publicado: (2018) -
Urinary Sodium Excretion Has Positive Correlation with Activation of Urinary Renin Angiotensin System and Reactive Oxygen Species in Hypertensive Chronic Kidney Disease
por: Ahn, Shin-Young, et al.
Publicado: (2014) -
Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants
por: Hwang, Jin Ho, et al.
Publicado: (2023)